2m 2m 2m 2m 2m 2m 2m
TONIX PHARM HLD (TNXP)
NASDAQ
$3.97+$0.10 (+2.58%)
Price as of Nov 12, 2026 8:28 AM EST- $66.4MMarket Cap
- -78.16%1-Year Change
- BiotechnologyIndustry
TONIX PHARM HLD (TNXP)
$3.97+$0.10 (+2.58%)
TNXP | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.87 | ||
Change | -$0.23 (-5.61%) | ||
Open | $4.16 | ||
High | $4.17 | ||
Low | $3.82 | ||
Previous Close | $4.10 | ||
Volume | 3,174,289 | ||
30-Day Average Volume | 1,041,189 | ||
1-Week Change | -24.27% | ||
1-Month Change | -46.99% | ||
1-Year Change | -78.16% | ||
3-Year Change | -99.74% | ||
5-Year Change | -100.00% | ||
Fundamentals | |||
Shares Outstanding | 19.4M | ||
Total Assets | $242.4M | ||
Market Cap | $66.4M | ||
Enterprise Value | -$96.4M | ||
Period: QTR TTM FY | |||
Revenue | $17.2M | ||
Net Income | -$53.3M | ||
Free Cash Flow | -$41.7M | ||
EBIT | -$53.3M | ||
EBITDA | -$52.7M | ||
Net Working Capital | $150.1M | ||
EPS | -$2.89 | ||
Enterprise Value/EBITDA | 2 | ||
Enterprise Value/Revenue | -6 | ||
P/B | 0 | ||
P/E | -1 | ||
PEG | 0 | ||
Price/Free Cash Flow | -2 | ||
Price/Operating Cash Flow | -2 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 100 | ||
Last Split Date | 02/05/2025 | ||
Earnings & Revenue